ABDOMINAL PERFUSION FOR CANCER CHEMOTHERAPY USING HYPOTHERMIA AND HYPERTHERMIA.
D000005:Abdomen; D000970:Antineoplastic Agents; D010478:Chemotherapy, Cancer, Regional Perfusion; D003110:Colonic Neoplasms; D003520:Cyclophosphamide; D005260:Female; D005853:Geriatrics; D006689:Hodgkin Disease; D006801:Humans; D007035:Hypothermia; D007036:Hypothermia, Induced; D007890:Leiomyosarcoma; D008466:Mechlorethamine; D008545:Melanoma; D008558:Melphalan; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms; D010190:Pancreatic Neoplasms; D010388:Pelvis; D012004:Rectal Neoplasms; D012186:Retroperitoneal Neoplasms; D002583:Uterine Cervical Neoplasms; D014625:Vaginal Neoplasms
D000970:Antineoplastic Agents; D008466:Mechlorethamine; D003520:Cyclophosphamide; D008558:Melphalan
ABDOMEN; ANTINEOPLASTIC AGENTS; CERVIX NEOPLASMS; COLONIC NEOPLASMS; CYCLOPHOSPHAMIDE; GERIATRICS; HODGKIN'S DISEASE; HYPOTHERMIA, INDUCED; ISOLATION PERFUSION; LEIOMYOSARCOMA; MECHLORETHAMINE; MELANOMA; MELPHALAN; NEOPLASM THERAPY; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PELVIS; RECTAL NEOPLASMS; RETROPERITONEAL NEOPLASMS; VAGINAL NEOPLASMS